CSF3 and acute myeloid leukemia: The use of granulocyte colony-stimulating factor (G-CSF), pegylated G-CSF, and granulocyte-macrophage CSF (GM-CSF) has been approved by the United States Food and Drug Administration for treating radiation injuries, such as acute myelogenous leukemia, neutropenia, and leukopenia [2, 3].